Condition: Vascular Diseases · Atherosclerosis · Sponsor: Göteborg University
Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.
This description comes directly from the study's public registry record.
Emma Borgeson, PhD · +46313420000 · emma.borgeson@wlab.gu.se
Per Skoog, MD, PhD · +46313420000 · per.skoog@vgregion.se
Always discuss trial participation with your own doctor first.
| University of Gothenburg | Gothenburg, Vastragotaland, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03732612